乳腺癌放疗对心脏CT冠状动脉疾病特征的影响
本回顾性病例对照研究将77例接受放疗的乳腺癌患者与77例倾向性评分匹配的对照者比较,发现两组在冠状动脉钙化积分、CAD-RADS评分、阻塞性病变率及高风险斑块表型率上均无显著差异,放疗组瓣膜纤维化及纤维粘连发生率亦无显著升高。
要点
- 乳腺癌放疗组与对照组冠状动脉钙化积分无显著差异(201.1 vs 75.4 AU,P = .64)。
- 放疗组与对照组阻塞性病变(>50%狭窄)率无显著差异(29% vs 23%,P = .46)。
- 放疗组左前降支或右冠状动脉与心腔纤维粘连率为对照组的1.4倍,但未达统计学显著(29% vs 13%,P = .46)。
核心结论
- 在本病例对照人群中,乳腺癌放疗与更严重的冠状动脉狭窄、高风险斑块表型或瓣膜纤维化无关。
研究设计与样本
- 回顾性病例对照研究,纳入154例女性患者(放疗组77例,对照组77例),按年龄、体重指数及主要心血管危险因素以P = .05水平进行倾向性评分匹配,评估冠状动脉CTA的钙化积分、CAD-RADS评分、高风险斑块表型及心外表现。
关键影像表现/征象
- 放疗组与对照组冠状动脉钙化积分无显著差异(201.1 vs 75.4 Agatston单位,P = .64)。
- 放疗组与对照组高风险斑块表型率无显著差异(9% vs 17%,P = .23)。
- 放疗组与对照组瓣膜纤维化发生率低且无显著差异(5% vs 3%,P = .68)。
- 放疗组与对照组瓣膜钙化发生率无显著差异(16% vs 9%,P = .37;OR 1.84,95%CI 0.68–5.25)。
- 放疗组左前降支或右冠状动脉与心腔纤维粘连率为29%,对照组为13%,差异未达统计学显著(P = .46;OR 1.41,95%CI 0.68–2.97)。
诊断标准与关键数值
- 阻塞性病变定义为狭窄>50%,放疗组29%(22/77) vs 对照组23%(18/77),P = .46,OR 1.31(95%CI 0.63–2.73)。
- 冠状动脉狭窄严重程度以CAD-RADS评分评估,两组间无显著差异(P = .40)。
- 左侧放疗 vs 右侧放疗的钙化积分(309 vs 120 AU,P = .23)、CAD-RADS评分(P = .43)及高风险斑块表型率(左侧11%[4/36] vs 右侧6%[2/34])均无显著差异。
临床应用与阅片要点
- 对乳腺癌放疗后患者行冠状动脉CTA时,可同时评估冠状动脉钙化积分、CAD-RADS评分及高风险斑块表型。
- 阅片时需注意观察瓣膜纤维化、瓣膜钙化及左前降支或右冠状动脉与心腔的纤维粘连等心外表现。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To evaluate the coronary artery disease (CAD) profile and valvular and structural alterations seen at coronary CT angiography (CTA) after radiation therapy (RT) for breast cancer in a case-control study. Materials and Methods Patients who underwent clinically indicated coronary CTA were included in this retrospective study. The following parameters were evaluated: coronary artery calcium (CAC) score, Coronary Artery Disease Reporting and Data System (CAD-RADS) score, high-risk plaque (HRP) phenotypes, and extracoronary findings (valvular fibrosis, fibrous adherence). Patients with breast cancer who underwent RT were propensity score-matched with controls (level: P = .05) for age, body mass index, and major cardiovascular risk factors to reduce selection bias and confounding. Results Among 154 female patients (mean age, 65.23 years ± 10.4 [SD]; 77 patients in RT group, 77 patients in control group), there was no evidence of a difference in CAC score between the RT and control groups (201.1 vs 75.4 Agatston units [AU], P = .64). No difference was seen in coronary stenosis severity (CAD-RADS score) (P = .40) or obstructive disease (>50% stenosis) rate (29% [22 of 77] vs 23% [18 of 77], P = .46; odds ratio [OR], 1.31 [95% CI: 0.63, 2.73]). No between-group difference was observed in high-risk plaque phenotype rate (9% [seven of 77] vs 17% [13 of 77], P = .23) or CAC or CAD-RADS scores. There was no evidence of a difference between left versus right RT for CAC (309 vs 120 AU, P = .23), coronary stenosis severity (CAD-RADS score, P = .43), or HRP phenotype rate (left, 11% [four of 36]; right, 6% [two of 34]). The prevalences of valvular fibrosis and calcifications were low (5% [four of 77] vs 3% [two of 77] [P = .68] and 16% [12 of 77] vs 9% [seven of 77] [P = .37], respectively; OR, 1.84 [95% CI: 0.68, 5.25]). The prevalence of fibrous adherence of the left anterior descending coronary artery or right coronary artery to the chambers was 1.4-fold higher in the RT group (29% [22 of 77] vs 13% [17 of 77] [P = .46]; OR, 1.41 [95% CI: 0.68, 2.97]). Conclusion RT for breast cancer was not associated with more severe coronary stenosis, HRP phenotypes, or valvular fibrosis in this case-control population cohort. Keywords: Coronary Arteries, Radiation Effects, CT-Coronary Angiography, Cardiac, Breast, Breast Cancer, Radiation Therapy, Cardiovascular Risk, Computed Tomography, Coronary Artery Disease Supplemental material is available for this article. © RSNA, 2026.
引用
- Deeg J, Swoboda M, Lacaita PG, et al. Impact of Radiation Therapy for Breast Cancer on the Coronary Artery Disease Profile at Cardiac CT. Radiol Cardiothorac Imaging. 2026. PMID: 41885623. doi:10.1148/ryct.250415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。